Nomogram to Predict Breast Cancer Related Lymphedema

Recruiting N/A Interventional Study
Breast Cancer Axillary Lymph Node Dissection Breast Cancer Related Lymphedema Axillary Reverse Mapping
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
600 (estimated)
Sponsor
Wuhan University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
It has been hypothesized that damaged arm lymphatic drainage is associated with the arm lymphedema after axillary lymph node dissection (ALND). However, the majority of breast cancer patients with complete ALND has not suffered from arm lymphedema, which appears to be due to the residual arm lymph nodes that has not been removed in the axillary dissection. With the compensation of the residual arm…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older with T1-3 invasive breast cancer; * Clinically node-positive breast cancer, defined as positive on preoperative axillary palpation, ultrasound examination, and computed tomography scan with contrast; * Patients who underwent mastectomy with a po…
Contacts

Qianqian Yuan, M.D.

13026322297

Yuanqq11@whu.edu.cn

CONTACT